Skip to content

Eric Furman, Ph.D.

Eric S. Furman, Ph.D. focuses on patent protection and other forms of intellectual property protection for biotechnology, pharmaceuticals, and medical devices.

Eric’s practice includes strategic patent counseling and procurement, freedom to operate analysis, counseling on infringement and invalidity issues, licensing, and due diligence studies as related to negotiations for mergers and acquisitions.

He currently represents clients with technology in the fields of genetically modified plants using RNAi methodologies, genetically modified organisms, stem cells, CAR T cells, prostate cancer therapeutics and other oncology pharmaceuticals, vaccines, medical devices, dietary supplements, diagnostic devices and assays, cleantech, industrial chemicals, and cosmetics.

Before joining the firm, Eric was a research assistant in the laboratory of Dr. Leroy Hood where he made transgenic mice with aberrant forms of myelin basic protein.  As a graduate student at the University of California, Los Angeles Medical School, he characterized transcription and splicing complexes, and was a teaching assistant for Donald S. Chisum, author of the preeminent treatise on patent law, while at law school.

University of Washington (UW), J.D.
University of California – Los Angeles – Medical School (UCLA), Ph.D., Biochemistry
University of New Mexico, B.S., Biology
State Bar of California
U.S. Patent and Trademark Office

Aesthetic & Cosmetic Biotechnology


Antibodies & Immunology


Biological Manufacturing of Chemicals


CBD & Legal Cannabis

Diagnostic Tools


Industrial Enzymes


Personalized Medicine

Plant Patents

Research Tools & Reagents

Stem Cells & Regenerative Medicine

Synthetic Biology & Nanotechnology


Tissue Engineering

Transgenic Animals

Transgenic Plants


Chemical, Industrial & Materials


Building Construction

Building Products & Materials

Chemical Engineering

Construction & Home Improvement

Cosmetics & Personal Care Products

Food Chemistry



HVAC & Passive Ventilation

Mining Chemicals

Oil & Gas

Pharmaceutical Chemistry


Consumer Products & Services

Aesthetics & Personal Care Products

Food & Beverage

Sporting Goods & Recreation

Electrical, Semiconductor & Computer Technology

Healthcare Information Technology


Biodegradable Materials

Bioenergy & Biofuels


Clean Technology

Drinking Water Treatment

Emissions Abatement

Geothermal Energy

Green Building & Construction

Green Chemistry


Remediation & Bioremediation

Wind Power

Financial Services & Business Methods

Licensing & Indemnification

Medical Devices & Procedures

Ablation Technology

Aesthetics & Implants

AI & Machine Learning

Annulus & Nucleus Repair

Dental Devices

Dermatology & Aesthetics


Drug Eluting & Drug Delivery Devices



Ischemic Stroke



Peripheral Artery Disease

Psychiatric & Neurological Conditions

Stents, Valves, & Delivery Systems

Tissue Engineering



Antibodies & Immunology

Biological Manufacturing of Chemicals


Diagnostic Tools


Personalized Medicine

Research Tools & Reagents

Stem Cells & Regenerative Medicine



Transportation & Vehicles

Air conditioning / Heating systems

Fuels & Additives

Design Patents
Global Portfolio Management
Infringement Risk 
Patent Strategy & Prosecution
U.S. Patent Prosecution

Named amongst Top 30 for Most Active Attorneys in Biotech in Patexia’s Patent Intelligence 2023 Report

Named one of the “World’s Leading Patent Professionals” in the Patent 1000 guide by Intellectual Asset Management (IAM) magazine for Prosecution (2020-2023)

Named among the “Top 25 Intellectual Property Portfolio Managers & Patent Prosecutors” by the Daily Journal in 2015.

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal